---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-054353"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2026-08-06T20:19:48+00:00"
generated_at: "2026-08-06T20:22:15.508828+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Globus Medical Q2 net sales $789.6M (+5.9%); non-GAAP EPS $1.34 (+55.8%), raises FY EPS guidance

## Summary
- Worldwide net sales $789.6M, +5.9% YoY; US +3.0%, International +18.0% as-reported.
- GAAP diluted EPS $1.10 (-26.2% YoY) due to prior-year bargain purchase gain; non-GAAP diluted EPS $1.34 (+55.8%).
- US Spine grew 7% YoY; International Spine grew 14% as-reported (12% constant currency).
- Adjusted gross margin expanded 200 bps YoY; record Q2 non-GAAP net income and EPS.
- FY2026 revenue guidance reaffirmed $3.18B-$3.22B; non-GAAP EPS guidance raised to $4.95-$5.05 from $4.70-$4.80.

## SEC filing metadata
- accession: 0001628280-26-054353
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2026-08-06T20:19:48+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000162828026054353/0001628280-26-054353-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000162828026054353/gmed-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-054353
- JSON: https://secwatch.observer/filing/0001628280-26-054353.json
- Plain text: https://secwatch.observer/filing/0001628280-26-054353.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.